Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.

The Journal of laboratory and clinical medicine - 1 Mar 2002

Martín Silvia, Pedro-Botet Juan, Joven Jorge, Simó Josep M, Ladona Margarita G, Pavesi Marco, Rubiés-Prat Juan

Abstract excerpt

Exactly how apolipoprotein a [APO(a)] isoform size affects the degree of cardiovascular risk associated with high lipoprotein a [LP(a)] levels is not fully understood. Using a sodium dodecyl sulfate-agarose APO(a) & LP(a) phenotyping method, we assessed the role of APO(a) size heterogeneity according to the number of kringle 4 repeats and the differential APO(a) protein expression in 91 male Spanish patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins A
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Coronary Disease

Share to Hyperlipoproteinemias

Share to Kringles

Share to Lipoprotein(a)

Share to Repetitive Sequences, Amino Acid

Source

Identifiers

PMID: 11944029
DOI: 10.1067/mlc.2002.121770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.PMID 11944029Read ↗

Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting.Semantic proximity Read ↗

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.Semantic proximity Read ↗

Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods.Semantic proximity Read ↗

Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.Semantic proximity Read ↗

Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipoprotein(a). A genetic risk factor for premature coronary heart diseaseSemantic proximity Read ↗

Differences between genotyping and phenotyping methods for assessing apolipoprotein(a) size polymorphisms.Semantic proximity Read ↗

Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).Semantic proximity Read ↗

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.Semantic proximity Read ↗

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.